| 1 |
28689102 | Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial. | 2017 Sep |
1 |
| 2 |
26867030 | The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies. | 2016 |
2 |
| 3 |
20445436 | Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic. | 2010 May |
2 |
| 4 |
19028832 | Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. | 2009 Mar |
2 |
| 5 |
19409854 | NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. | 2009 Jun |
1 |
| 6 |
15261560 | Corticosteroids treatment. | 2004 Aug 15 |
2 |
| 7 |
11389809 | Optic Neuritis. | 2001 Jul |
1 |
| 8 |
8862132 | Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes. | 1996 Oct |
4 |